跳至主要内容
临床试验/EUCTR2005-001525-28-GB
EUCTR2005-001525-28-GB进行中(未招募)1 期

INFLUENCE OF THE ANTIOXIDANT N-ACETYLCYSTEINE ON INHALED NITRIC OXIDE INDUCED PULMONARY RESPONSES FOLLOWING HUMAN LUNG ISCHAEMIA-REPERFUSION INJURY

Imperial College London0 个研究点目标入组 43 人开始时间: 2006年2月14日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The expected study population will include patients undergoing lung, heart-lung and heart transplantation who meet the following inclusion criteria
  • 1. The patients exhibit a moderate degree of impaired gas exchange (PaO2/FiO2 ratios within the range of 150-300 mmHg) or pulmonary hypertension (mean PAP > 25 mmHg) and increased pulmonary vascular resistance (PVR > 250 dynes x sec/cm-5) in the postoperative period
  • 2. Greater than 18 years of age
  • 3. signed IRB approved informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Severe lung injury with PaO2/FiO2 ratios < 150 mmHg in patients who are potential candidates for rescue therapy with iNO on clinical grounds
  • 2. Received intravenous nitrate therapy or other investigational drug within the 24 hours preceding surgery
  • 3. Pregnancy
  • 4. Patients with asthma. This group will be excluded in view of potential bronchospasm as an adverse effect of N-acetylcysteine

研究者

相似试验